Literature DB >> 12183572

Increased host resistance against Pneumocystis carinii pneumonia in gammadelta T-cell-deficient mice: protective role of gamma interferon and CD8(+) T cells.

Chad Steele1, Mingquan Zheng, Erana Young, Luis Marrero, Judd E Shellito, Jay K Kolls.   

Abstract

Although a clear relationship between alphabeta T-cell receptor-positive (alphabeta-TCR(+)) CD4(+) T cells and susceptibility to Pneumocystis carinii infection exists, the role of other T-cell subsets is less clearly defined. Previous studies have shown that gammadelta-TCR(+) T cells infiltrate into the lung during P. carinii pneumonia. Therefore, the present study examined the role of gammadelta-TCR(+) T cells in host defense against P. carinii pneumonia. C57BL/6 (control) and B6.129P2-Tcrd(tm1Mom) (gammadelta-TCR(+) T-cell-deficient) mice were inoculated intratracheally with P. carinii. At specific time points, mice were sacrificed and analyzed for P. carinii burden, T-cell subsets, and cytokine levels in lung tissue. Analysis of P. carinii burden showed a more rapid and complete resolution of infection in gammadelta-TCR(+) T-cell-deficient mice than in C57BL/6 controls. This augmented resolution was associated with elevated gamma interferon (IFN-gamma) levels in bronchoalveolar lavage fluid predominantly produced by CD8(+) T cells, as well as an increased recruitment of CD8(+) T cells in general. In separate experiments, neutralization of IFN-gamma or depletion of CD8(+) T cells early during infection abolished the augmented resolution previously observed in gammadelta-TCR(+) T-cell-deficient mice. These results show that the presence of gammadelta-TCR(+) T cells modulates host susceptibility to P. carinii pneumonia through interactions with pulmonary CD8(+) T cells and tissue production of IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183572      PMCID: PMC128275          DOI: 10.1128/IAI.70.9.5208-5215.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Exaggerated proinflammatory and Th1 responses in the absence of gamma/delta T cells after infection with Listeria monocytogenes.

Authors:  M J Skeen; E P Rix; M M Freeman; H K Ziegler
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

2.  Effect on parasite eradication of Pneumocystis carinii-specific antibodies produced in the presence or absence of CD4(+) alphabeta T lymphocytes.

Authors:  R Hanano; S H Kaufmann
Journal:  Eur J Immunol       Date:  1999-08       Impact factor: 5.532

3.  CD4+ T cell-independent vaccination against Pneumocystis carinii in mice.

Authors:  M Zheng; J E Shellito; L Marrero; Q Zhong; S Julian; P Ye; V Wallace; P Schwarzenberger; J K Kolls
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 4.  Gene therapy to modify pulmonary host defenses.

Authors:  J K Kolls; P Ye; J E Shellito
Journal:  Semin Respir Infect       Date:  2001-03

5.  Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia.

Authors:  T W Wright; F Gigliotti; J N Finkelstein; J T McBride; C L An; A G Harmsen
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

6.  A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes.

Authors:  J Shellito; V V Suzara; W Blumenfeld; J M Beck; H J Steger; T H Ermak
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

7.  The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.

Authors:  N J Ives; B G Gazzard; P J Easterbrook
Journal:  J Infect       Date:  2001-02       Impact factor: 6.072

8.  Gamma delta-T cells are critical for survival and early proinflammatory cytokine gene expression during murine Klebsiella pneumonia.

Authors:  T A Moore; B B Moore; M W Newstead; T J Standiford
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

9.  Opportunistic infections in persons with HIV or other immunocompromising conditions.

Authors:  J E Kaplan; K Sepkowitz; H Masur; T Sirisanthana; M Russo; L Chapman
Journal:  Emerg Infect Dis       Date:  2001       Impact factor: 6.883

10.  The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group.

Authors:  J Phair; A Muñoz; R Detels; R Kaslow; C Rinaldo; A Saah
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

View more
  24 in total

1.  Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection.

Authors:  Kyle I Happel; Mingquan Zheng; Erana Young; Lee J Quinton; Euan Lockhart; Alistair J Ramsay; Judd E Shellito; Jill R Schurr; Gregory J Bagby; Steve Nelson; Jay K Kolls
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

2.  Experimental Pneumocystis lung infection promotes M2a alveolar macrophage-derived MMP12 production.

Authors:  Michael P Nelson; Benjamin S Christmann; Chad W Dunaway; Alison Morris; Chad Steele
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-06       Impact factor: 5.464

3.  Sensitized CD8+ T cells fail to control organism burden but accelerate the onset of lung injury during Pneumocystis carinii pneumonia.

Authors:  Francis Gigliotti; Elliott L Crow; Samir P Bhagwat; Terry W Wright
Journal:  Infect Immun       Date:  2006-08-28       Impact factor: 3.441

4.  Gammadelta T cells and Th17 cytokines in hypersensitivity pneumonitis and lung fibrosis.

Authors:  Philip L Simonian; Christina L Roark; Willi K Born; Rebecca L O'Brien; Andrew P Fontenot
Journal:  Transl Res       Date:  2009-09-09       Impact factor: 7.012

5.  IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina.

Authors:  Michael P Nelson; Benjamin S Christmann; Jessica L Werner; Allison E Metz; Jennifer L Trevor; Clifford A Lowell; Chad Steele
Journal:  J Immunol       Date:  2011-01-10       Impact factor: 5.422

6.  Treatment with Interleukin-7 Restores Host Defense against Pneumocystis in CD4+ T-Lymphocyte-Depleted Mice.

Authors:  S Ruan; D R Samuelson; B Assouline; M Morre; J E Shellito
Journal:  Infect Immun       Date:  2015-10-19       Impact factor: 3.441

7.  Pneumocystis infection in an immunocompetent host can promote collateral sensitization to respiratory antigens.

Authors:  Steve D Swain; Nicole Meissner; Soo Han; Allen Harmsen
Journal:  Infect Immun       Date:  2011-02-22       Impact factor: 3.441

8.  Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of pneumocystis pneumonia.

Authors:  Laura McKinley; Alison J Logar; Florencia McAllister; Mingquan Zheng; Chad Steele; Jay K Kolls
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

9.  Pulmonary Interleukin-17-Positive Lymphocytes Increase during Pneumocystis murina Infection but Are Not Required for Clearance of Pneumocystis.

Authors:  Chiara Ripamonti; Lisa R Bishop; Joseph A Kovacs
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

10.  Exogenous heat-killed Escherichia coli improves alveolar macrophage activity and reduces Pneumocystis carinii lung burden in infant mice.

Authors:  Kerry M Empey; Melissa Hollifield; Beth A Garvy
Journal:  Infect Immun       Date:  2007-05-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.